Potential Nephrotoxicity of Lisinopril and Valsartan on Patients with Congestive Heart Failure
Lisinopril (angiotensin converting enzyme inhibitor) and valsartan (angiotensin II receptor blocker) are the first-line treatment for patients with congestive heart failure (CHF). These two drugs potentially cause side effects on renal functions. However, limited information was available regardi...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universitas Padjadjaran
2017-04-01
|
| Series: | Pharmacology and Clinical Pharmacy Research |